Get started
Author

Fahad Hassan Baali

Observed names: Fahad H Baali, Fahad H. Baali
Institution: Taif University
Observed institution: Taif University
ORCID: 0009-0001-6889-515X
Observed ORCID: 0009-0001-6889-515X
OpenAlex ID: A5115653716
Breast Cancer: Insights into Risk Factors, Pathogenesis, Diagnosis and Management
2015 · Ahmed M. Kabel, Fahad H. Baali · The Journal of Cancer Research · 41
Determinants of Public Knowledge, Attitude, and Practice on Antibiotic Use in Saudi Arabia: A Regional Cross-Sectional Study
2025 · Wadia S. Alruqayb, Fahad H. Baali, et al. · Healthcare · 8
PDF
Public perceptions and influencing factors of seasonal influenza vaccine uptake in Makkah region, Saudi Arabia: a cross-sectional study
2025 · Mohammed S. Alharthi, Abdullah A. Alshehri, et al. · Frontiers in Public Health · 7
PDF
Prevalence and patterns of dietary supplement use and potential drug interactions among older adults in Saudi Arabia
2025 · Wael Y. Khawagi, Majd M. Alghamdi, et al. · Frontiers in Pharmacology · 5
PDF
Evaluating the bioavailability and therapeutic efficacy of nintedanib-loaded novasomes as a therapy for non-small cell lung cancer
2025 · Tamer M. Mahmoud, Amr Gamal Fouad, et al. · Journal of Pharmaceutical Sciences · 5
Exploring the association between serum magnesium level and autism spectrum disorder using validated spectrofluorimetric method
2024 · Atiah H. Almalki, Ahmed K. Bamaga, et al. · Analytical Biochemistry · 4
Vericiguat Enhances Olfactory Function in Post-Infectious Anosmia: A Randomized Pilot Double-Blind Placebo-Controlled Trial
2025 · Adnan Alharbi, Mohamed H. Abdelazim, et al. · American Journal of Rhinology and Allergy · 3
Topical Glutamate Diacetate: A Promising Therapy for Post-Coronavirus Disease 2019 Olfactory Dysfunction Through Calcium Modulation
2025 · Majed A. Algarni, Mohammed S. Alharthi, et al. · American Journal of Rhinology and Allergy · 3
A Cross-Sectional Survey on the Management of Medication Adherence Among Healthcare Professionals in Saudi Arabia
2025 · Wael Y. Khawagi, Fahad H. Baali, et al. · Healthcare · 3
PDF
Improving the bioavailability and therapeutic efficacy of valsartan for the control of cardiotoxicity-associated breast cancer
2025 · Mary Eskander Attia, Fatma I. Abo El-Ela, et al. · Journal of drug targeting · 2
Spectrofluorimetric determination of cyclic guanosine monophosphate in human nasal secretions: evaluating levels in healthy individuals and patients with olfactory dysfunction
2025 · Mohamed H. Abdelazim, Faisal Alsenani, et al. · BMC Chemistry · 2
PDF
Unraveling the mechanisms of glioblastoma’s resistance: investigating the influence of tumor suppressor p53 and non-coding RNAs
2024 · Qamar A. Alshammari, Saud O. Alshammari, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2
Histone Deacetylase Inhibitors: A Hope for Cancer Patients
2015 · Ahmed M. Kabel, Fahad H. Baali · The Journal of Cancer Research · 2
Patient Activation Among Individuals with Chronic Illness: A Cross-Sectional Study from Jordan
2026 · Mohammad B. Nusair, Rawand Khasawneh, et al. · Healthcare · 1
PDF
Impact of pharmacist counseling intervention to improve health-related quality of life in pulmonary tuberculosis: a randomized controlled trial
2025 · Rabbiya Ahmad, Siti Maisharah Sheikh Ghadzi, et al. · IJID Regions · 1
In vitro and in vivo evaluation of the therapeutic efficacy of in-situ pH-sensitive carvedilol-loaded novasomes as a therapy for diabetes-associated coronary artery disease
2025 · Amr Gamal Fouad, Amany Belal, et al. · Journal of drug targeting · 1
Knowledge, attitudes, and practices among users of GLP-1 receptor agonists in Saudi Arabia: a cross-sectional study
2026 · Abdullah A. Alshehri, Mohammed K. Al-Osaimi, et al. · Frontiers in Pharmacology
PDF
Invasomes nanocarriers for targeted delivery of letrozole derivative: A novel strategy to mitigate breast cancer
2026 · Wael A.A. Fadaly, Seif E. Ahmed, et al. · Journal of Pharmaceutical Sciences
Ufasomal nanocarriers for enhanced cardiac delivery of nifedipine: a novel strategy to mitigate doxorubicin-induced cardiotoxicity in breast cancer therapy
2026 · Hanan O. Farouk, Fatma I. Abo El-Ela, et al. · Journal of drug targeting
Independent Pharmacist Prescribing in Pediatric and Neonatal Settings: A Systematic Review of Clinical Impact, Barriers, and Facilitators
2026 · Saeed Saad A. Alghamdi, Fahad H. Baali
PDF
Control of cardiotoxicity via nasal in-situ pH-sensitive transbilosomal formulation of candesartan
2026 · Mohamed A. M. Ali, Amany Belal, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology
Knowledge, attitudes, and practices toward xylometazoline nasal spray use among adults in Saudi Arabia: a cross-sectional survey
2026 · Fahad H. Baali, Abdullah A. Alshehri, et al. · Frontiers in Pharmacology
PDF
Comparative Efficacy of Anti-Obesity Medications on Cardiovascular and Renal Outcomes in Non-Diabetic Patients: A Network Meta-Analysis
2026 · Fahad H. Baali, Saeed Saad A. Alghamdi
Erratum to ``Childhood Obesity: Global Burden, Multifactorial Etiologies, Biological Mechanisms, and Emerging Interventions for Prevention and Management'' [Saudi Medical Journal 2026; 47(2):183–194]
2026 · Fahad H. Baali · Saudi Medical Journal
Spectrofluorimetric determination of serum homovanillic acid using horseradish peroxidase and its association with autism spectrum disorder
2026 · Razaz A. Felemban, Ahmed K. Bamaga, et al. · Scientific Reports
PDF
Works count: 32
Citation count: 90
H-index: 5
I10-index: 1
Year
Topic
Type